halobetasol
Selected indexed studies
- Halobetasol propionate for the management of psoriasis. (Cutis, 2020) [PMID:32186526]
- Halobetasol. (, 2006) [PMID:29999958]
- Halobetasol Cream. (, 2026) [PMID:31334954]
_Worker-drafted node — pending editorial review._
Connections
halobetasol is a side effect of
Sources
- Halobetasol propionate for the management of psoriasis. (2020) pubmed
- Halobetasol. (2006) pubmed
- Halobetasol Cream. (2026) pubmed
- A critical review of halobetasol propionate foam (0.05%) as a treatment option for adolescent plaque psoriasis. (2022) pubmed
- Dermatopharmacologic investigations of halobetasol propionate in comparison with clobetasol 17-propionate. (1991) pubmed
- Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials. (2020) pubmed
- Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits. (2021) pubmed
- Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults. (2020) pubmed
- Halobetasol Propionate 0.01% Lotion for Plaque Psoriasis and Corticosteroid-Responsive Dermatoses. (2022) pubmed
- PMID:33570887 (2020) pubmed